loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Ivosidenib NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DOTTIKON EXCLUSIVE SYNTHESIS AG (1)

filter

01 Ivosidenib (1)

filter

01 Switzerland (1)

URL Supplier Web Content
Ivosidenib
POWDER (1kg/kg)
BULK INGREDIENT
54864-720
2018-07-20
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1448347-49-6 / Ivosidenib API manufacturers, exporters & distributors?

Ivosidenib manufacturers, exporters & distributors 1

65

PharmaCompass offers a list of Ivosidenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ivosidenib manufacturer or Ivosidenib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ivosidenib manufacturer or Ivosidenib supplier.

PharmaCompass also assists you with knowing the Ivosidenib API Price utilized in the formulation of products. Ivosidenib API Price is not always fixed or binding as the Ivosidenib Price is obtained through a variety of data sources. The Ivosidenib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ivosidenib

Synonyms

1448347-49-6, Tibsovo, Ag-120, Ag120, Ivosidenib [inn], Ivosidenib [usan]

Cas Number

1448347-49-6

Unique Ingredient Identifier (UNII)

Q2PCN8MAM6

About Ivosidenib

Ivosidenib is an orally available inhibitor of isocitrate dehydrogenase type 1 (IDH1), with potential antineoplastic activity. Upon administration, AG-120 specifically inhibits a mutated form of IDH1 in the cytoplasm, which inhibits the formation of the oncometabolite, 2-hydroxyglutarate (2HG). This may lead to both an induction of cellular differentiation and an inhibition of cellular proliferation in IDH1-expressing tumor cells. IDH1, an enzyme in the citric acid cycle, is mutated in a variety of cancers; it initiates and drives cancer growth by both blocking cell differentiation and catalyzing the formation of 2HG.

Ivosidenib Manufacturers

A Ivosidenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ivosidenib, including repackagers and relabelers. The FDA regulates Ivosidenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ivosidenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ivosidenib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ivosidenib Suppliers

A Ivosidenib supplier is an individual or a company that provides Ivosidenib active pharmaceutical ingredient (API) or Ivosidenib finished formulations upon request. The Ivosidenib suppliers may include Ivosidenib API manufacturers, exporters, distributors and traders.

click here to find a list of Ivosidenib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ivosidenib NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ivosidenib as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Ivosidenib API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Ivosidenib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Ivosidenib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ivosidenib NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Ivosidenib suppliers with NDC on PharmaCompass.

Ivosidenib Manufacturers | Traders | Suppliers

Ivosidenib Manufacturers, Traders, Suppliers 1
39

We have 1 companies offering Ivosidenib

Get in contact with the supplier of your choice:

  1. DOTTIKON EXCLUSIVE SYNTHESIS AG
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY